Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
CASH FLOWS PROVIDED/(USED) BY OPERATING ACTIVITIES
Net income	$ 8,837	$ 1,303
Adjustments to reconcile net loss to net cash provided/(used) by operating activities:
Depreciation and amortization	751	1,065
Extinguishment of PPP loan		(2,045)
Loss on extinguishment of term debt	792
Gain on sale of Microlab	(16,403)
Amortization of debt issuance fees	55	150
Share-based compensation expense	650	203
Deferred rent	(15)	(15)
Deferred income taxes	2,677	320
Provision for doubtful accounts	(16)	71
Inventory reserves	28	85
Changes in assets and liabilities, net of divestiture:
Accounts receivable	(1,581)	(1,079)
Inventories	(457)	(645)
Prepaid expenses and other assets	(57)	319
Accounts payable	304	585
Deferred revenue	(257)
Accrued expenses and other liabilities	(842)	77
Net cash provided/(used) by operating activities	(5,534)	394
CASH FLOWS PROVIDED/(USED) BY INVESTING ACTIVITIES
Capital expenditures	(326)	(313)
Deferred purchase price payment	(250)	(200)
Divestiture of Microlab, net	22,753
Net cash provided/(used) by investing activities	22,177	(513)
CASH FLOWS USED BY FINANCING ACTIVITIES
Term loan repayments	(4,432)	(470)
Acquisition of treasury stock	(2,525)
Payment of contingent consideration	(658)	(105)
Proceeds from exercise of stock options	24
Shares withheld for employee taxes	(19)	(17)
Net cash used by financing activities	(7,610)	(592)
Effect of Exchange Rate Changes on Cash and Cash Equivalents	(167)	14
NET INCREASE/(DECREASE) IN CASH AND CASH EQUIVALENTS	8,866	(697)
Cash and Cash Equivalents, at Beginning of Period	4,472	4,910
CASH AND CASH EQUIVALENTS, AT END OF PERIOD	13,338	4,213
SUPPLEMENTAL INFORMATION:
Cash paid during the period for interest	122	204
Cash paid during the period for income taxes	$ 597	$ 110